Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,025 public trials 2,027 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

NCT04858568

Conditions
Burkitt Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +42 more
Locations
  • Bedfordshire Hospitals NHS Foundation Trust Bedford, Bedfordshire, United Kingdom
  • Portsmouth Hospitals University NHS Trust Portsmouth, Hampshire, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
  • Wye Valley NHS Trust Hereford, Herefordshire, United Kingdom
View Trial Details
Completed

TDM of Asparaginase in ALL2008

NCT04843514

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Aarhus University Hospital, Denmark Aarhus N, Denmark
  • Aarhus University Hospital Aarhus N, Denmark
View Trial Details
Completed

A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma

NCT02961881

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
View all 17 locations
View Trial Details
Completed

Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.

NCT01041508

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Nationwide Childrens Hospital Columbus, Ohio, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Vanderbilt Children's Hospital Nashville, Tennessee, United States
View Trial Details
Completed

Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma

NCT00075946

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
View all 483 locations
View Trial Details
Completed

A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma

NCT02561962

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Research Site West Hollywood, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Houston, Texas, United States
View Trial Details

Related conditions